MedPath

Brace Versus No Brace for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury

Not Applicable
Completed
Conditions
Thoracolumbar Burst Fractures Without Neurologic Deficit
Registration Number
NCT01741168
Lead Sponsor
The London Spine Centre
Brief Summary

Braces have been used o treat stable (not requiring surgery) burst fractures with much success. Recently questions have been raised in regards to the importance of the brace. Some studies have results that suggest a brace is not important in having a good outcome. However, this has never been proven. This study is being conducted to see whether or not wearing a brace is important to having a good outcome.

Detailed Description

The purpose of this study is to prospectively compare the outcome between patients randomly assigned to a thoracolumbosacral orthosis (TLSO) treatment group or no orthosis (NO) treatment group, for the management of an acute AO type A3 thoracolumbar fracture.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • AO A3 burst fracture between T10 and L3 with associated kyphotic deformity <35 degrees
  • neurologically intact or isolated nerve root deficit
  • age 16-60 years
  • enrollment within 3 days of injury
Exclusion Criteria
  • neurological deficit
  • can not comply with brace wearing (pregnancy/body mass index >40)
  • mobilized with or without a brace prior to recruitment
  • suffered a pathologic or open fracture
  • alcohol or drug abusers
  • had previous injury or surgery to the thoracolumbar region
  • unable to complete the questionnaires

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Roland Morris Disability Questionnaire3 months post fracture

The primary outcome measure is the Roland Morris Disability Questionnaire (RMDQ) administered at 3 months post fracture. The RMDQ evaluates physical disability secondary to low back pain and is validated, simple to administer, sensitive, and reliable. The questionnaire evaluates 24 items to derive a score that varies between zero (no disability) and twenty-four (severe disability). Three months was chosen because it is the time point at which we expect a significant functional recovery and readiness to resume most normal activities.

Secondary Outcome Measures
NameTimeMethod
SF-36 physical component summary scoreenrollment, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2years
SF-36 mental component summary scoreenrollment, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years
VAS pain scoreenrollment, 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months
Satisfaction with Treatmentenrollment, 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months

Overall satisfaction with treatment was assessed on a seven point scale, using the sentence, "All things considered, how satisfied are you with the results of your recent treatment for your spine fracture?" This is a recommended tool for assessing global satisfaction.

Trial Locations

Locations (1)

London Spine Centre

🇨🇦

London, Ontario, Canada

London Spine Centre
🇨🇦London, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.